BIO Web Conf.
Volume 22, 2020International Conference “Longevity Interventions 2020” (ICLI 2020)
|Number of page(s)||7|
|Section||Actual Problems of Medicine|
|Published online||06 July 2020|
Obtaining hepatocytes by transdifferentiation of multipotent mesenchymal stromal cells by genetic engineering
Ural State Medical University, 620028, Repin Str., 3, Ekaterinburg, Russian Federation
2 Institute of Medical Cell Technology, 620026, Ekaterinburg, Russian Federation
3 Ural Federal University, 620002, Mira Str., 19, Ekaterinburg, Russian Federation
Therapy of liver failure is a common and insufficiently resolved problem. One of the options for its solution it is a liver transplantation. However, this method has a number of drawbacks, which include a limited number of donors and transplant rejection. The use of autologous hepatocytes would allow significant progress to solve the problem under discussion. The work considers a method that allowed obtaining autologous hepatocytes by transdifferentiation of multipotent mesenchymal stromal cells using genetic engineering methods.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.